Forskolin Increases the Effect of Everolimus on Aromatase Inhibitor-Resistant Breast Cancer Cells

Oncotarget - United States
doi 10.18632/oncotarget.25217
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Profiles of miRNAs Matched to Biology in Aromatase Inhibitor Resistant Breast Cancer

Oncotarget
Oncology
2016English

Aromatase Explains Why Testosterone Increases Breast Cancer Rate

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2009English

EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells

Asian Pacific Journal of Cancer Prevention
2019English

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Breast Care
SurgeryOncology
2010English

Everolimus Restrains the Paracrine Pro-Osteoclast Activity of Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

The Effect of Exercise on Aromatase Inhibitor-Induced Musculoskeletal Symptoms in Breast Cancer Survivors :A Systematic Review and Meta-Analysis

Supportive Care in Cancer
Oncology
2019English

Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells in Vitro

PLoS ONE
Multidisciplinary
2015English

The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients With Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy